Summary:
A phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Trial of Brexpiprazole in Treatment of Children and Adolescents with Irritability Associated with Autism Spectrum Disorder.
Qualified Participants Must:
• Age 5 to 17 years of age
•
Diagnosis of Autism Spectrum Disorder
Qualified Participants May Receive:
Transportation provided and no health insurance necessary